Coastal Dermatology

CLIA Laboratory Citation Details

2
Total Citations
12
Total Deficiencyies
5
Unique D-Tags
CMS Certification Number 45D0950291
Address 1310 34th Street N Suite C, Texas City, TX, 77590
City Texas City
State TX
Zip Code77590
Phone(409) 948-8557

Citation History (2 surveys)

Survey - August 13, 2024

Survey Type: Standard

Survey Event ID: OXZE11

Deficiency Tags: D0000 D5473 D0000 D5473

Summary:

Summary Statement of Deficiencies D0000 Noted deficiencies and plans of correction were discussed with the laboratory representative(s) at the exit conference. The facility was found to be in compliance with applicable Conditions in the CLIA program, and recertification is recommended. D5473 CONTROL PROCEDURES CFR(s): 493.1256(e)(2)(g) (e) For reagent, media, and supply checks, the laboratory must do the following: (e) (2) Each day of use (unless otherwise specified in this subpart), test staining materials for intended reactivity to ensure predictable staining characteristics. Control materials for both positive and negative reactivity must be included, as appropriate. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on the review of the laboratory's policy, CMS 116 application form, , CMS 209 Laboratory Personnel Report (CLIA) form, H&E Stain QC logs from January 2024 to July 2024, and confirmed in an interview, the laboratory failed to document H&E stain QC acceptability for 19 of 19 days by the testing personnel. The findings were: 1. Review of the laboratory's policy revealed no stain QC acceptability policy. 2. Review of the laboratory's CMS 116 application form, signed by the laboratory director on 08/12/2024, revealed the laboratory's operation hours was 7:00 am to 2:00 pm on Mondays. 3. Review of the laboratory's CMS 209 Laboratory Personnel Report (CLIA) form, signed by the laboratory director on 08/08/2024, revealed the laboratory identified 1 testing personnel which was the laboratory director. 4. Review of the laboratory's H&E stain QC logs from January 2024 to July 2024 revealed no documentation of H&E stain QC acceptability for 19 of 19 days by the testing personnel. 01/15/2024 01/22/2024 01/29/2024 02/05/2024 02/12/2024 02/26/2024 03 /04/2024 03/25/2024 04/15/2024 05/01/2024 05/13/2024 05/20/2024 06/03/2024 06/10 /2024 06/17/2024 07/01/2024 07/15/2024 07/22/2024 07/29/2024 5. Review of the laboratory's CMS 116 application form, signed by the laboratory director on 08/12 Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- /2024, revealed the laboratory's annual volume was 165. 6. An interview with the technical consultant on 08/13/2024 at 10:40 am in the laboratory confirmed the above findings. Key: CMS= Center of Medicare and Medicaid Services QC=Quality Control H&E=Hematoxylin & Eosin -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - December 17, 2018

Survey Type: Standard

Survey Event ID: 51HQ11

Deficiency Tags: D0000 D5217 D5291 D5413 D0000 D5217 D5291 D5413

Summary:

Summary Statement of Deficiencies D0000 Noted deficiencies and plans of correction were discussed with the laboratory representative(s) at the exit conference. The facility representative(s) were given an opportunity to provide evidence of compliance with the noted deficiencies, and no such evidence was provided prior to survey exit. The facility was found to be in compliance with applicable Conditions of Participation in the CLIA program, and recertification is recommended. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on review of the laboratory records and confirmed in an interview, the laboratory failed to document at least twice annually the accuracy of 1 of 1 tests in 2017. (Mohs) Findings were: 1. A review of laboratory testing records from 2017 and 2018 revealed no documentation of the laboratory verifying the accuracy for the Mohs test for 2017. 2. An interview with laboratory director on 12/17/18 at 1350 hours in the laboratory confirmed the above findings. He stated that he thinks it was performed but he didn't know where the documentation was kept. D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on review of the laboratory policies, laboratory records, and confirmed in interview, the laboratory quality assessment failed to identify that the laboratory did not perform and/or assess the twice annual accuracy assessment for all tests performed in the laboratory. Findings were: 1. Review of the laboratory policy Quality Assurance (QAQC.01, approved 8/21/17) revealed "the laboratory participates in a peer review twice a year. This peer review is the reciprocal reading of randomly selected cases/slides by another qualified physician." 2. Review of the laboratory records revealed no documentation of the twice annual accuracy for 2017. Cross refer to D5217. 3. An interview with the laboratory director on 12/17/18 at 1405 hours in the laboratory confirmed the above findings. D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on review of the manufacturer's instructions, laboratory records, patient final reports and confirmed in interview, the laboratory failed to have documentation to monitor the operating temperature and humidity for the Avantik QS12 cryostat for the Mohs histopathology testing. Findings were: 1. Review of the instructions for use for the Avantik QS12 cryostat (388159) revealed the operating environment as 15-30 C and humidity up to 60%. 2. Review of the laboratory records from 2017 through 2018 revealed no documentation of the laboratory monitoring the room temperature or humidity. 3. Random review of patient test records from 2017 and 2018 revealed the laboratory performed patient testing. Patient ID date 17-001 020/8/17 17-006 03/13 /17 17-010 04/03/17 17-026 06/05/17 17-031 07/10/17 17-044 09/11/17 17-052 10/02 /17 17-064 11/06/17 17-070 12/04/17 18-006 1/29/18 18-016 02/26/18 18-055 08/06 /18 18-062 10/15/18 18-067 11/05/18 4. An interview with the laboratory director on 12/17/18 at 1410 hours in the laboratory confirmed the above findings. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access